AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE
Clinical trials for AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE explained in plain language.
Never miss a new study
Get alerted when new AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE trials appear
Sign up with your email to follow new studies for AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Diabetes drug metformin tested to protect kidneys in PKD patients
Disease control Recruiting nowThis study tests whether metformin, a widely used diabetes medication, can slow the loss of kidney function in people with early-stage autosomal dominant polycystic kidney disease (ADPKD). Researchers will compare metformin to a placebo in 1,174 adults aged 18-70 over two years. …
Matched conditions: AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE
Phase: PHASE3 • Sponsor: The University of Queensland • Aim: Disease control
Last updated May 17, 2026 03:10 UTC
-
New drug AZD1613 tested for safety in kidney disease patients
Disease control Recruiting nowThis early-stage study tests the safety of a new drug called AZD1613 in 40 adults with autosomal dominant polycystic kidney disease (ADPKD). Participants receive either the drug or a placebo to check for side effects and how the drug moves through the body. The goal is to see if …
Matched conditions: AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 13, 2026 15:59 UTC
-
New drug aims to shrink cysts in genetic kidney disease
Disease control Recruiting nowThis study tests an investigational drug called ABBV-CLS-628 in adults with autosomal dominant polycystic kidney disease (ADPKD), a genetic condition that causes fluid-filled cysts to grow in the kidneys. About 240 participants will receive either the drug or a placebo by IV ever…
Matched conditions: AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE
Phase: PHASE2 • Sponsor: AbbVie • Aim: Disease control
Last updated May 05, 2026 11:54 UTC
-
Kidney disease drug study: will empagliflozin change mineral balance?
Knowledge-focused Recruiting nowThis study looks at how Empagliflozin, a diabetes drug, affects calcium, phosphate, and magnesium levels in people with autosomal dominant polycystic kidney disease (ADPKD). About 40 adults will take either the drug or a placebo for 2 weeks, then switch. The goal is to understand…
Matched conditions: AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE
Phase: PHASE2 • Sponsor: Cantonal Hospital Graubuenden • Aim: Knowledge-focused
Last updated May 17, 2026 03:12 UTC
-
New biomarker study aims to track kidney disease progression
Knowledge-focused Recruiting nowThis study is for people with early autosomal dominant polycystic kidney disease (ADPKD). Researchers want to see if certain substances in urine and blood can show how active the disease is. About 60 participants aged 15-40 will provide samples and have an MRI. The goal is to fin…
Matched conditions: AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 17, 2026 03:09 UTC
-
New study aims to uncover hidden signs of kidney disease progression
Knowledge-focused Recruiting nowThis study looks at how the body handles stress and damage in the early stages of a genetic kidney disease called ADPKD. Researchers will measure certain substances in blood and urine from 40 adults aged 18-30. The goal is to find markers that could help track the disease better …
Matched conditions: AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 14, 2026 12:01 UTC